Atlas Trials

Cancer Research UK

83 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Cancer Research UK

RecordFirmDate
DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. (NCT07440290)Cancer Research UK2026-04-01
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers. (NCT05770544)Cancer Research UK2025-11-30
DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations (NCT06988475)Cancer Research UK2024-11-19
A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer (NCT06380816)Cancer Research UK2024-07-09
A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies (NCT06045910)Cancer Research UK2024-02-07
DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers (NCT05770037)Cancer Research UK2023-12-18
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition (NCT05770102)Cancer Research UK2023-10-25
HTL0039732 in Participants With Advanced Solid Tumours (NCT05944237)Cancer Research UK2023-07-13
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations (NCT05786716)Cancer Research UK2023-03-07
DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol (NCT05722886)Cancer Research UK2023-03-01
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. (NCT05768178)Cancer Research UK2023-03-01
TT-702 in Patients With Advanced Solid Tumours. (NCT05272709)Cancer Research UK2022-01-19
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours (NCT05057013)Cancer Research UK2021-11-10
A Trial of ChAdOx1 and MVA Vaccines Against MAGE-A3 and NY-ESO-1 (NCT04908111)Cancer Research UK2021-10-15
A Trial Looking at the Use of Camostat in People Who Have Tested Positive for Coronavirus (COVID-19) (SPIKE-1) (NCT04455815)Cancer Research UK2020-09-23
AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer (NCT03371485)Cancer Research UK2018-05-29
BT1718 in Patients with Advanced Solid Tumours. (NCT03486730)Cancer Research UK2018-01-24

Track Cancer Research UK automatically

Every clearance here is in the API, with alerts when new ones post.